241 related articles for article (PubMed ID: 21867837)
1. Homocysteine and reclassification of cardiovascular disease risk.
Veeranna V; Zalawadiya SK; Niraj A; Pradhan J; Ference B; Burack RC; Jacob S; Afonso L
J Am Coll Cardiol; 2011 Aug; 58(10):1025-33. PubMed ID: 21867837
[TBL] [Abstract][Full Text] [Related]
2. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.
Shah N; Parikh V; Patel N; Patel N; Badheka A; Deshmukh A; Rathod A; Lafferty J
Int J Cardiol; 2014 Feb; 171(3):390-7. PubMed ID: 24388541
[TBL] [Abstract][Full Text] [Related]
4. Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
Park CS; Ihm SH; Yoo KD; Kim DB; Lee JM; Kim HY; Chung WS; Seung KB; Kim JH
Am J Cardiol; 2010 May; 105(9):1284-8. PubMed ID: 20403480
[TBL] [Abstract][Full Text] [Related]
5. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III.
Shah N; Pahuja M; Pant S; Handa A; Agarwal V; Patel N; Dusaj R
Int J Cardiol; 2017 Apr; 232():105-110. PubMed ID: 28117138
[TBL] [Abstract][Full Text] [Related]
6. Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study.
Elias-Smale SE; Wieberdink RG; Odink AE; Hofman A; Hunink MG; Koudstaal PJ; Krestin GP; Breteler MM; van der Lugt A; Witteman JC
Eur Heart J; 2011 Aug; 32(16):2050-8. PubMed ID: 21606087
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-III.
Badheka AO; Patel N; Tuliani TA; Rathod A; Marzouka GR; Zalawadiya S; Deshmukh A; Moscucci M; Cohen MG
Am J Med; 2013 Apr; 126(4):319-326.e2. PubMed ID: 23415052
[TBL] [Abstract][Full Text] [Related]
8. Lone mothers are at higher risk for cardiovascular disease compared with partnered mothers. Data from the National Health and Nutrition Examination Survey III (NHANES III).
Young LE; Cunningham SL; Buist DS
Health Care Women Int; 2005 Aug; 26(7):604-21. PubMed ID: 16126603
[TBL] [Abstract][Full Text] [Related]
9. ST-T wave abnormality in lead aVR and reclassification of cardiovascular risk (from the National Health and Nutrition Examination Survey-III).
Badheka AO; Patel NJ; Grover PM; Shah N; Singh V; Deshmukh A; Mehta K; Chothani A; Hoosien M; Rathod A; Savani GT; Marzouka GR; Gupta S; Mitrani RD; Moscucci M; Cohen MG
Am J Cardiol; 2013 Sep; 112(6):805-10. PubMed ID: 23764245
[TBL] [Abstract][Full Text] [Related]
10. Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA).
Nasir K; Budoff MJ; Wong ND; Scheuner M; Herrington D; Arnett DK; Szklo M; Greenland P; Blumenthal RS
Circulation; 2007 Aug; 116(6):619-26. PubMed ID: 17646582
[TBL] [Abstract][Full Text] [Related]
11. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
12. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Albert MA; Glynn RJ; Buring J; Ridker PM
Circulation; 2006 Dec; 114(24):2619-26. PubMed ID: 17116764
[TBL] [Abstract][Full Text] [Related]
13. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults.
Zalawadiya SK; Gunasekaran PC; Bavishi CP; Veeranna V; Panaich S; Afonso L
Eur J Prev Cardiol; 2015 May; 22(5):673-9. PubMed ID: 24699336
[TBL] [Abstract][Full Text] [Related]
16. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
[TBL] [Abstract][Full Text] [Related]
17. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
[TBL] [Abstract][Full Text] [Related]
18. An Electrocardiogram-Based Risk Equation for Incident Cardiovascular Disease From the National Health and Nutrition Examination Survey.
Shah AJ; Vaccarino V; Janssens AC; Flanders WD; Kundu S; Veledar E; Wilson PW; Soliman EZ
JAMA Cardiol; 2016 Oct; 1(7):779-786. PubMed ID: 27487404
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP across Framingham risk categories: data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Dhangana R; Murphy TP; Pencina MJ; Zafar AM
Atherosclerosis; 2011 May; 216(1):174-9. PubMed ID: 21414621
[TBL] [Abstract][Full Text] [Related]
20. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
